EZL
Asset Logo

Euroz Hartleys Group Limited

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿ’ธ FINANCIALS

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ฐ Dividends

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

-2.80%
Annual Growth

5 years average annual growth

๐Ÿ’ฐ

5.52%
Annual dividend yield

Based on the most recent dividend

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

1
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Euroz Hartleys Group Ltd. engages in the business of financial solutions. The company is headquartered in Perth, Western Australia. The firm specializes in the provision of wealth management, stockbroking, corporate finance, institutional sales and targeted research services. The Companyโ€™s segments include Private Wealth, Wholesale, Funds Management, others. The private segment includes private wealth advisers who work with high net wealth individuals, companies, SMSF and other clients. The Private wealth advisers provide investment offering of stockbroking and corporate services for clients. The Wholesale segment refers to the institutional dealing, research and corporate finance team who work with companies and other institutional clients. The Fund Management segment include Westoz Funds Management Pty Ltd, which is an investment fund whose purpose is to generate positive returns from a portfolio of stocks with a focus on the resources sector in Western Australia. The company also offers portfolio administration and reporting.

๐Ÿ“ˆ Performance

Price History

-11.49%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ฐ Dividends

Payouts

๐Ÿ’ฐ Annual Dividend Yield*

5.52%

๐Ÿ’ฐ Annual Dividend Earnings Per $1,000 invested**

$55.23

๐Ÿ’ฐ Most Recent Dividend Franked Percentage Estimate

100.00%

๐Ÿ’ฐ Average Dividend Franked Percentage Estimate

100.00 %

๐Ÿ’ฐ Dividend reinvestment

Learn more

* Based on the most recent dividend

** Calculated by multiplying the most recent dividend yield by $1,000

Estimate your dividend

If you held

$

of EZL, your last dividend payment(s) would have been:

$ 478.85

on Fri Aug 30 2024

$ 280.9

on Fri Feb 16 2024

*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.

Dividend History

1Y

5Y

10Y

Graph

Table

Year
Yearly Dividend Earnings Per Share
Franking Estimate

2025

$0.00

0.00%

2024

$0.05

100.00%

2023

$0.06

100.00%

2022

$0.31

50.00%

2021

$0.16

100.00%

2020

$0.08

100.00%

2019

$0.07

100.00%

2018

$0.11

100.00%

2017

$0.07

100.00%

2016

$0.04

100.00%

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$0.92

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in EZL

1

๐Ÿ“Š Total Capital Earnings

$5K

๐Ÿ”ƒ Average investment frequency

17 weeks

๐Ÿ’ต Average investment amount

$3,893

โฐ Last time a customer invested in EZL

67 days
EZL investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

100%
๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

35 - 90

100%
๐Ÿ™‹ Legal gender of investors

Female

100%

Male

Pearlers who invest in EZL also invest in...

Pilbara Minerals Limited

PLS

Pilbara Minerals Ltd. engages in the exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 917 full-time employees. The company went IPO on 2007-09-19. The firm is primarily engaged in the exploration, development, and mining of minerals in Australia. Its 100% owned Pilgangoora hard-rock lithium operation is located approximately 120 kilometers (kms) from Port Hedland in Western Australiaโ€™s resource-rich Pilbara region. The operation consists of two processing plants: the Pilgan Plant, located on the northern side of the Pilgangoora area and produces spodumene and tantalite concentrates, and the Ngungaju Plant is located to the south produces spodumene concentrate. The company owns 70% of the Mt Francisco project, which is located 50 km south-west of the Pilgangoora Project and hosts the large occurrence of outcropping pegmatites located nearby to Port Hedland. The company is also pursuing a proposed downstream joint venture (JV) for the development of an approximately 43,000 tons per annum (tpa) lithium carbonate equivalent (LCE) lithium chemical conversion facility in South Korea.

๐Ÿ™Œ Performance (5Yr p.a)

113.27%

๐Ÿ“Š Share price

$2.39 AUD

โ›๏ธ MINING

Find Out More

ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).

๐Ÿ™Œ Performance (5Yr p.a)

12.97%

๐Ÿ“Š Share price

$91.00 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ›๏ธ CONSUMER

๐Ÿญ INDUSTRIALS

๐ŸŒ GLOBAL

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

๐Ÿ™Œ Performance (5Yr p.a)

19.54%

๐Ÿ“Š Share price

$63.85 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ‡บ๐Ÿ‡ธ UNITED STATES

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

๐Ÿ™Œ Performance (5Yr p.a)

24.85%

๐Ÿ“Š Share price

$50.66 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ‡บ๐Ÿ‡ธ UNITED STATES

๐Ÿค– TECHNOLOGY

RBTZ.AX was created on 2018-09-12 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. RBTZ.AX aims to track the performance of an index (before fees and expenses) that includes global companies involved in the production or use of robotics and artificial intelligence (A.l.) products and services.

๐Ÿ™Œ Performance (5Yr p.a)

8.42%

๐Ÿ“Š Share price

$15.22 AUD

๐Ÿ‡ฆ๐Ÿ‡บ EX AUSTRALIA

๐Ÿค– TECHNOLOGY

๐Ÿ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

EZZ Life Science Holdings Ltd. is a genomic life science company, which engages in the business of formulating, producing, marketing, and selling branded health and wellbeing products to retailers and consumers domestically and internationally. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-03-03. The firm has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), children's health, and weight management. The firm's segments include Brought in Lines and Company Owned products. Its portfolio includes EZZ and EAORON. The EZZ-branded product range encompasses a broad selection of health and wellbeing products, catering to individuals across all age groups and owned by the Company. The EAORON-branded products comprise a range of facial care items, and the Company serves as the exclusive distributor in Australia and New Zealand for selected channels. The EZZ-branded products include EZZ Hair Growth Spray Duo, EZZ Multi Vitamins Milk Powder for Children (for children ages three plus), EZZ KidzSure Formulated Nutrition Powder (for children ages three plus) and EZZ VitalSure Formulated Nutrition Powder (for adults).

๐Ÿ“Š Share price

$2.39 AUD

๐Ÿ”ญ LIFE SCIENCES TOOLS & SERVICES

F100.AX was created on 2019-07-12 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to track the price and income performance of the FTSE 100 Index (before fees and expenses). The Index provides exposure to the largest 100 comoanies traded on the London Stock Exchange, based on their market capitalisation.

๐Ÿ™Œ Performance (5Yr p.a)

2.80%

๐Ÿ“Š Share price

$12.47 AUD

โ›ณ๏ธ DIVERSIFIED

UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND

๐ŸŒ GLOBAL

๐Ÿ“Š Share price

$0.00 AUD

Nova Eye Medical Ltd. engages in developing suite of novel ophthalmic treatment technologies. The company is headquartered in Adelaide, South Australia. The firm operates through three segments: AlphaRET, and Glaucoma surgical devices. The Companyโ€™s AlphaRET segment is responsible for the commercialization of the 2RT ophthalmic laser, which is an ophthalmic laser developed for the therapy of patients in the early to intermediate stages of age-related macular degeneration (AMD). 2RT is a patented nano-pulse laser device that rejuvenates retinal structures compromised by AMD. The Glaucoma Surgical Devices segment includes the designing, manufacturing, marketing, and sale of the iTrack, iTrack Advance and the Molteno3 glaucoma surgical device. The Molteno3 glaucoma drainage device platform is designed to enhance surgical utility and optimize clinical outcomes for long-term intraocular pressure (IOP) control in cases of severe glaucoma.

๐Ÿ™Œ Performance (5Yr p.a)

-11.54%

๐Ÿ“Š Share price

$0.17 AUD

๐Ÿฉบ HEALTH CARE

Compare
Add to watchlist